RxNorm
U.S. National Library of Medicine (NIH)
The Rosetta Stone that maps every US drug product, NDC, and brand name to a standard ID.
A normalized naming system for clinical drugs in the US that links ingredients, strengths, dose forms, brand names, and package codes (NDCs) across commercial drug vocabularies. It is the plumbing that lets researchers combine prescription data from different sources. NLM provides monthly files and the free RxNav API.
Access
- Cost
- FreeFree; the full release files require a free UMLS license account, while the RxNav API and a prescribable subset need none.
- License
- Provider's own termsUMLS Metathesaurus License
- Sign-up
- Free account
- How you get it
- API and Bulk downloadRRF (pipe-delimited), JSON via API
What's in it
- One row is
- One concept per normalized drug name, with relationships between concepts
- Covers
- United States drug market
- Years
- Current, with archived releases
- Updated
- Monthly
- Size
- Not stated
Quality
The national standard for drug naming, maintained by NLM with regular releases.
- Relational file format has a learning curve
- Some source vocabularies have redistribution restrictions
- Covers US products only
Connects to
- Medicaid State Drug Utilization Data: Map NDCs to ingredients
- DrugBank: Link clinical drug names to pharmacology
- FDA Adverse Event Reporting System (FAERS): Normalize free-text drug names in reports
Questions it could answer
- How many distinct products contain a given ingredient?
- How do you roll up NDC-level spending to ingredient level?